1. Screening of women with aesthetic prostheses in dedicated sessions of a population-based breast cancer screening programme
- Author
-
Lucia Bracchi, Lauro Bucchi, Silvana Castaldi, Silvia Deandrea, Stella Pedilarco, Maria Silvia Sfondrini, Mauro Campoleoni, Anan Judina Bastiampillai, Ester Luconi, Anna Silvestri, Laura Cavazzana, Antonio Piscitelli, and N. Principi
- Subjects
medicine.medical_specialty ,Referral ,Breast Implants ,Population ,Breast Neoplasms ,Population based ,030230 surgery ,030218 nuclear medicine & medical imaging ,Screening programme ,03 medical and health sciences ,Breast cancer screening ,0302 clinical medicine ,Humans ,Mass Screening ,Medicine ,Mammography ,Radiology, Nuclear Medicine and imaging ,Diagnostic screening programmes ,education ,Early Detection of Cancer ,Aged ,Retrospective Studies ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,Obstetrics ,Incidence ,General Medicine ,Clinical breast examination ,Middle Aged ,Italy ,Population Surveillance ,Cohort ,Breast Radiology ,Female ,business - Abstract
Background Women with aesthetic prostheses must be included in the target population of mammography screening programmes. Breast implants are radiopaque and partially obscure the breast tissue. This can be avoided with the use of the Eklund technique, which causes an increased radiation exposure. In this study, augmented women undergoing a dedicated protocol within a population-based screening programme were compared according to selected indicators with the standard screening population. Essential dosimetric parameters and their time trend were also assessed. Materials and methods The study was conducted in a screening centre in Milan in the years 2009–2016. The screening protocol for women with breast implants included a double-read mammography with the Eklund views, ultrasound and clinical breast examination. Results A total of 28,794 women were enrolled, including 588 (2%) women with breast implants and 28,206 (98%) undergoing the standard screening protocol. The invasive assessment rate was 9.0‰ for women with breast implants vs. 15‰ in the standard cohort. The surgical referral rate was 2.2% vs. 0.9%. The detection rate was similar in the two groups (4.0 and 4.5‰, respectively). There were significant differences in the average glandular dose according to the mammography equipment. The use of the Eklund views increased over time. Conclusions Screening of augmented women according to a specific protocol in the contexts of population-based programmes is feasible. Observed differences in screening indicators relative to the standard screening population require further research. The increasing use of Eklund views probably results from quality assurance measures associated with screening programmes.
- Published
- 2021